Can’t Buy SpaceX? Rocket Lab (RKLB) Stock Is the Next Best Thing

TLDR

• RKLB rose 3.2% on Monday, trading as high as $116.25 before closing at $113.65, on below-average volume
• CEO Peter Beck stated only two companies have successfully scaled space launch, reinforcing RKLB’s position
• Analysts remain bullish, with Deutsche Bank and TD Cowen both setting $120 price targets; consensus is Moderate Buy
• CIBC Asset Management raised its stake by 36.5%, with institutional investors owning 71.78% of the stock
• Insiders sold 485,515 shares worth ~$66.9M in the last 90 days, mostly to cover tax obligations on vesting equity

Rocket Lab (RKLB) gained 3.2% on Monday, touching $116.25 intraday before settling at $113.65. Volume was roughly 45% below the daily average at around 13.3 million shares traded.

Rocket Lab USA, Inc., RKLB

The stock’s one-year range sits between $25.24 and $151.00, and it currently trades about 24% off that high.

The move came on a relatively quiet news day, but a handful of positive catalysts have been building.

CEO Peter Beck made headlines recently by claiming only two companies have successfully scaled space launch — a comment that put Rocket Lab squarely in an elite bracket and got investors paying attention.

There’s also growing interest in RKLB as a proxy play on the space economy ahead of SpaceX’s anticipated IPO. For investors who want space exposure without waiting for SpaceX to go public, Rocket Lab is the most obvious public-market option right now.

Analyst Price Targets Keep Moving Higher

Several firms have raised their price targets in recent weeks. Deutsche Bank lifted its target from $73 to $120 with a Buy rating. TD Cowen made the same move, going from $90 to $120. Needham raised theirs from $95 to $120. New Street Research started coverage with a Buy and a $150 target.

Stifel Nicolaus set a $132 target. The consensus sits at Moderate Buy with an average price target of $98.88, though several individual targets are well above that.

BTIG maintained a Hold, and Zacks downgraded from Strong Buy to Hold back in February. So not everyone is on board.

Institutional Buying Continues

CIBC Asset Management increased its position by 36.5% in Q4, picking up 5,604 additional shares for a total of 20,971 shares worth roughly $1.46 million.

Vanguard grew its stake by 13.4% in Q4, now holding over 47.4 million shares valued at around $3.3 billion. Swiss National Bank raised its position by 67.7% in Q3. Institutional investors now own 71.78% of the company.

On the insider side, SVP Arjun Kampani sold 70,000 shares at $145.13 on May 27th, and insider Marvin Bradford Clevenger sold 15,549 shares at $142.57 on May 26th. Both sales were made under pre-arranged 10b5-1 plans to cover tax withholding on vesting equity awards.

In Q1, RKLB posted revenue of $200.35 million, beating the $189.65 million consensus estimate. That was up 63.4% year-over-year. EPS came in at -$0.07, in line with expectations. Analysts expect -$0.29 EPS for the full fiscal year.

The stock carries a market cap of $65.77 billion, a beta of 2.48, and a debt-to-equity ratio of just 0.02.

The post Can’t Buy SpaceX? Rocket Lab (RKLB) Stock Is the Next Best Thing appeared first on CoinCentral.